CY1107352T1 - Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου - Google Patents

Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου

Info

Publication number
CY1107352T1
CY1107352T1 CY20081100328T CY081100328T CY1107352T1 CY 1107352 T1 CY1107352 T1 CY 1107352T1 CY 20081100328 T CY20081100328 T CY 20081100328T CY 081100328 T CY081100328 T CY 081100328T CY 1107352 T1 CY1107352 T1 CY 1107352T1
Authority
CY
Cyprus
Prior art keywords
therapeutic purpose
surgery
dosage form
postoperative pain
operative therapeutic
Prior art date
Application number
CY20081100328T
Other languages
Greek (el)
English (en)
Inventor
Bruce E Reidenberg
Daniel A Spyker
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1107352T1 publication Critical patent/CY1107352T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Processing Of Meat And Fish (AREA)
  • Prostheses (AREA)
CY20081100328T 2003-07-25 2008-03-21 Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου CY1107352T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
EP04779185A EP1638492B1 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Publications (1)

Publication Number Publication Date
CY1107352T1 true CY1107352T1 (el) 2012-12-19

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100328T CY1107352T1 (el) 2003-07-25 2008-03-21 Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου

Country Status (27)

Country Link
US (3) US20080026042A1 (https=)
EP (1) EP1638492B1 (https=)
JP (1) JP5632573B2 (https=)
KR (4) KR20090031961A (https=)
CN (1) CN1829489B (https=)
AT (1) ATE382354T1 (https=)
AU (1) AU2004261181B2 (https=)
BR (1) BRPI0412924A (https=)
CA (1) CA2529983C (https=)
CY (1) CY1107352T1 (https=)
DE (1) DE602004011055T2 (https=)
DK (1) DK1638492T3 (https=)
EA (1) EA009213B1 (https=)
ES (1) ES2299871T3 (https=)
GE (1) GEP201606538B (https=)
HR (1) HRP20080146T3 (https=)
IL (1) IL173345A (https=)
IS (1) IS8186A (https=)
MA (1) MA28005A1 (https=)
MX (1) MXPA06000990A (https=)
NO (1) NO326636B1 (https=)
NZ (1) NZ594154A (https=)
PL (1) PL1638492T3 (https=)
PT (1) PT1638492E (https=)
UA (1) UA81689C2 (https=)
WO (1) WO2005011578A2 (https=)
ZA (1) ZA200510071B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
EP2611445B1 (en) * 2010-09-03 2018-08-15 Zoetis Belgium S.A. High dose buprenorphine compositions and use as analgesic
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
WO2024055006A2 (en) * 2022-09-09 2024-03-14 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
EP0484543B1 (en) * 1990-04-24 1995-12-13 Teijin Limited Plaster
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
WO2001093868A1 (fr) * 2000-06-02 2001-12-13 Teijin Limited Bande adhesive contenant de la buprenorphine
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
EP2266719B1 (en) * 2001-04-23 2016-06-08 Euro-Celtique S.A. Disposal system for transdermal dosage form
SI2062573T1 (sl) * 2001-05-01 2012-02-29 Euro Celtique Sa Proti zlorabi odporni transdermalni sistemi, ki vsebujejo opioid
JP4302991B2 (ja) * 2001-05-22 2009-07-29 ユーロ−セルティーク エス.エイ. 経皮性剤形を分配する容器及び装置
AU2003297073A1 (en) * 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia

Also Published As

Publication number Publication date
AU2004261181B2 (en) 2009-08-06
DE602004011055T2 (de) 2008-12-18
MXPA06000990A (es) 2006-04-11
US20080026042A1 (en) 2008-01-31
JP2007500133A (ja) 2007-01-11
KR20060054346A (ko) 2006-05-22
ATE382354T1 (de) 2008-01-15
EP1638492B1 (en) 2008-01-02
AU2004261181A1 (en) 2005-02-10
GEP201606538B (en) 2016-09-12
EA009213B1 (ru) 2007-12-28
HK1087907A1 (en) 2006-10-27
CA2529983C (en) 2010-07-20
KR20120128715A (ko) 2012-11-27
JP5632573B2 (ja) 2014-11-26
UA81689C2 (ru) 2008-01-25
HRP20080146T3 (en) 2008-04-30
EA200600284A1 (ru) 2006-06-30
KR20090031961A (ko) 2009-03-30
WO2005011578A3 (en) 2005-09-09
MA28005A1 (fr) 2006-07-03
ES2299871T3 (es) 2008-06-01
IL173345A (en) 2010-06-16
BRPI0412924A (pt) 2006-09-26
DE602004011055D1 (de) 2008-02-14
ZA200510071B (en) 2006-11-29
EP1638492A2 (en) 2006-03-29
PT1638492E (pt) 2008-03-17
CN1829489B (zh) 2010-12-15
DK1638492T3 (da) 2008-05-13
NO326636B1 (no) 2009-01-26
IS8186A (is) 2005-12-19
US20110002975A1 (en) 2011-01-06
KR20080011248A (ko) 2008-01-31
CN1829489A (zh) 2006-09-06
NO20060912L (no) 2006-04-21
US20140221413A1 (en) 2014-08-07
EP1638492A4 (en) 2006-07-19
NZ594154A (en) 2012-12-21
WO2005011578A2 (en) 2005-02-10
CA2529983A1 (en) 2005-02-10
IL173345A0 (en) 2006-06-11
PL1638492T3 (pl) 2008-06-30

Similar Documents

Publication Publication Date Title
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
BRPI0406667A (pt) Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
DK1476141T3 (da) Manipulationssikrede anordninger til transdermal opioidadministration
WO2009129509A3 (en) Methods and compositions for treating post-operative pain comprising a local anesthetic
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
BRPI0418029A (pt) formulação de anticorpos cd40 e métodos
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE330600T1 (de) Kombinationspräparat zur krebstherapie
Mulroy Ambulatory Surgery
NO20043774L (no) The use of devazenide as analgesic agent
TH93888A (https=)